Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06418633 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotablePrimary and study completion pushed from Apr 1, 2028 to Apr 1, 2030v6
NotablePrimary and study completion dates: Apr 1, 2027 to Apr 1, 2028v5
NotableTrial status: Not Yet Recruiting to RecruitingStudy sites: 0 to 1 · Start date changed from estimate of Apr 15, 2025 to Feb 11, 2025v4Show 2 more changesShow less
Study sites: 0 to 1
Start date changed from estimate of Apr 15, 2025 to Feb 11, 2025
NotablePrimary completion date: Nov 1, 2025 to Apr 1, 2027Start date: Nov 15, 2024 to Apr 15, 2025 · Completion date: Nov 1, 2026 to Apr 1, 2027v3Show 2 more changesShow less
Start date: Nov 15, 2024 to Apr 15, 2025
Completion date: Nov 1, 2026 to Apr 1, 2027
NotablePrimary completion date: May 1, 2025 to Nov 1, 2025Start date: May 15, 2024 to Nov 15, 2024 · Completion date: May 1, 2026 to Nov 1, 2026v2Show 2 more changesShow less
Start date: May 15, 2024 to Nov 15, 2024
Completion date: May 1, 2026 to Nov 1, 2026
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Two groups of patients will be compared: One group of patients with a history of venous thromboembolic disease and one group without. Both groups will be subjected to a walking test and with electrocardiogram measurements and blood tests.